TylenolRecall

Johnson & Johnson Recalls Tylenol Products on Odor Complaints

Johnson & Johnson (JNJ) is recalling Tylenol products because of a musty odor, the company%u2019s third such recall in 12 months. J&J is yanking a line of Tylenol 8-hour caplets containing 127,728 bottles after customers complained of a musty smell from the pills, Bloomberg News said. The smell may be related to a chemical that is applied to wooden pallets used to store packing materials.

J&J Apologizes for Kids Medicine Issues, Phantom Recalls

In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.

Johnson & Johnson Earnings Up, but Recalls Cut Guidance

Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.

No New Children's Tylenol on Shelves This Year

Johnson & Johnson said Thursday that the Fort Washington, Pa., facility where it produced children's medications will probably stay shut down for the rest of 2010, meaning that no new supplies of those medicines will be available this year.

These Days, a Good Reputation Is Everything

Some companies don't realize how important their reputations are until they're gone, but a new survey of corporate directors shows that reputational risk is their second biggest worry. It should be: As much as 70% of a company's value may rest on that one intangible asset.

J&J Recall Hearing: Contradictions and Cover-Ups

At Congress' hearings on Johnson & Johnson's huge recall of Children's Tylenol, among other drugs, the company's statements were contradicted by the Food and Drug Administration, and details of J&J's Motrin "phantom recall" were revealed.

J&J's Motrin Recall Cover-Up Revealed

Ahead of a Congressional hearing over Johnson & Johnson's big drug recall, internal documents were revealed that showed the drugmaker trying to conduct a stealth recall of Motrin in 2008. That's just one of the series of problems discovered at J&J.